|
|
|
|
Дата |
|---|
| 07.04.2025 |
| 06.04.2025 |
| 03.04.2025 |
| 02.04.2025 |
| 27.03.2025 |
| 26.03.2025 |
| 25.03.2025 |
| 24.03.2025 |
| 23.03.2025 |
| 20.03.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
36.78
|
36.23
|
37.80
|
37.01
|
|
|
649 417.56
|
81.00
|
|
|
|
39.00
|
32.66
|
37.50
|
36.78
|
|
|
1 490 070.78
|
158.00
|
|
|
|
39.56
|
38.75
|
39.39
|
39.00
|
|
|
649 540.83
|
46.00
|
|
|
|
39.25
|
39.05
|
39.89
|
39.56
|
|
|
791 946.25
|
62.00
|
|
|
|
39.25
|
39.05
|
39.89
|
39.56
|
|
|
791 946.25
|
62.00
|
|
|
|
39.01
|
38.80
|
39.68
|
39.25
|
|
|
718 518.15
|
65.00
|
|
|
|
39.42
|
38.70
|
39.79
|
39.01
|
|
|
3 277 689.13
|
158.00
|
|
|
|
39.17
|
38.70
|
39.65
|
39.42
|
|
|
1 277 539.65
|
94.00
|
|
|
|
38.37
|
38.01
|
39.60
|
39.17
|
|
|
853 728.95
|
83.00
|
|
|
|
37.90
|
37.70
|
38.90
|
38.37
|
|
|
961 729.26
|
96.00
|
Период |
|---|
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
